Article,

Molecular modeling and cytotoxicity of diffractaic acid: HP-beta-CD inclusion complex encapsulated in microspheres

, , , , , , , , , , , and .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, (2016)
DOI: 10.1016/j.ijbiomac.2016.06.073

Abstract

In this pioneer study, 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) was used to improve the solubility of the diffractaic acid (DA) via inclusion complex (DA:HP-beta-CD). Subsequently, DA:HP-beta-CD was incorporated into poly-epsilon-caprolactone (PCL) microspheres (DA:HP-beta-CD-MS). Microspheres containing DA (DA-MS) or DA:HP-beta-CD (DA:HP-beta-CD-MS) were prepared using the multiple W/O/W emulsion-solvent evaporation technique. The phase-solubility diagram of DA in HP-beta-CD (10-50mM) showed an A(L) type curve with a stability constant K-1:1=821 M-1. H-1 NMR, FTIR, X-ray diffraction and thermal analysis showed changes in the molecular environment of DA in DA:HP-beta-CD. The molecular modeling approach suggests a guest-host complex formation between the carboxylic moiety of both DA and the host (HP-beta-CD). The mean particle size of the microspheres were ODA-MS=5.23 +/- 1.65 mu m and ODA:HP-beta-CD-MS = 4.11 +/- 1.39 mu m, respectively. The zeta potential values of the microspheres were zeta(DA-MS) = -7.85 +/- 0.32 mV and zeta(DA):(HP-beta-CD-MS) = -6.93 +/- 0.46mV. Moreover, the encapsulation of DA:HP-beta-CD into microspheres resulted in a more slower release (k(2)=0.042 +/- 0.001; r(2) = 0.996) when compared with DA-MS (k(2)= 0.183 +/- 0.005; r(2) = 0.996). The encapsulation of DA or DA:HP-beta-CD into microspheres reduced the cytotoxicity of DA (IC50 = 43.29 mu M) against Vero cells (IC50 of DA-MS = 108.48 mu M and IC50 of DA:HP-beta-CD-MS = 142.63 mu M). (C) 2016 Elsevier B.V. All rights reserved.

Tags

Users

  • @ppgfis_ufc_br

Comments and Reviews